# Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma

> **NCT06983704** · EARLY_PHASE1 · COMPLETED · sponsor: **Benha University** · enrollment: 50 (actual)

## Conditions studied

- Pediatric Glaucoma

## Interventions

- **PROCEDURE:** AGV plate
- **PROCEDURE:** bevacizumab injection

## Key facts

- **NCT ID:** NCT06983704
- **Lead sponsor:** Benha University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-09
- **Primary completion:** 2025-02-08
- **Final completion:** 2025-02-15
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06983704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06983704, "Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06983704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*